Cargando…
The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their m...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296629/ https://www.ncbi.nlm.nih.gov/pubmed/37370838 http://dx.doi.org/10.3390/cancers15123226 |
_version_ | 1785063694755954688 |
---|---|
author | Merk-Ahmad, Katrin Bein, Julia Scharf, Sonja Schäfer, Hendrik Bexte, Tobias Ullrich, Evelyn Loth, Andreas G. Flinner, Nadine Senff, Tina Schneider, Olga Hansmann, Martin-Leo Piel, Matthieu Häupl, Björn Oellerich, Thomas Donnadieu, Emmanuel Hartmann, Sylvia |
author_facet | Merk-Ahmad, Katrin Bein, Julia Scharf, Sonja Schäfer, Hendrik Bexte, Tobias Ullrich, Evelyn Loth, Andreas G. Flinner, Nadine Senff, Tina Schneider, Olga Hansmann, Martin-Leo Piel, Matthieu Häupl, Björn Oellerich, Thomas Donnadieu, Emmanuel Hartmann, Sylvia |
author_sort | Merk-Ahmad, Katrin |
collection | PubMed |
description | SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their migration capacity neither in microfluidics microchannels, 3D collagen gel or primary human lymphoid tissue. In contrast, RHOA-G17V overexpressing cells from the HH cell line presented increased numbers of cells surrounded by cleaved collagen. Primary AITL cases showed a correlation between RHOA-G17V mutation allele frequency and collagen fibrosis of the tissue, suggesting that mechanisms leading to extracellular matrix degradation contribute to the early spread of AITL tumor cells. ABSTRACT: Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the RHOA mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because RHOA is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did not exhibit enhanced motility compared to empty-vector-transfected cells in microchannels, a 3D collagen gel, or primary human lymphatic tissue. Cells of the HH cell line expressing RHOA-G17V had an increased number of cells with cleaved collagen compared with the empty-vector-transfected cells. Therefore, we hypothesized that the early spread of AITL tumor cells may be related to remodelling of the extracellular matrix. Accordingly, we observed a significant negative correlation between the relative area of collagen in histological sections from 18 primary AITL and the allele frequency of the RHOA-G17V mutation. In conclusion, our results suggest that the characteristic presentation of AITL with early, widespread dissemination of lymphoma cells is not the result of an enhanced migration capacity due to the RHOA-G17V mutation; instead, this feature may rather be related to extracellular matrix remodelling. |
format | Online Article Text |
id | pubmed-10296629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102966292023-06-28 The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling Merk-Ahmad, Katrin Bein, Julia Scharf, Sonja Schäfer, Hendrik Bexte, Tobias Ullrich, Evelyn Loth, Andreas G. Flinner, Nadine Senff, Tina Schneider, Olga Hansmann, Martin-Leo Piel, Matthieu Häupl, Björn Oellerich, Thomas Donnadieu, Emmanuel Hartmann, Sylvia Cancers (Basel) Article SIMPLE SUMMARY: The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. Overexpression of RHOA-G17V in malignant T cells did not enhance their migration capacity neither in microfluidics microchannels, 3D collagen gel or primary human lymphoid tissue. In contrast, RHOA-G17V overexpressing cells from the HH cell line presented increased numbers of cells surrounded by cleaved collagen. Primary AITL cases showed a correlation between RHOA-G17V mutation allele frequency and collagen fibrosis of the tissue, suggesting that mechanisms leading to extracellular matrix degradation contribute to the early spread of AITL tumor cells. ABSTRACT: Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the RHOA mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because RHOA is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did not exhibit enhanced motility compared to empty-vector-transfected cells in microchannels, a 3D collagen gel, or primary human lymphatic tissue. Cells of the HH cell line expressing RHOA-G17V had an increased number of cells with cleaved collagen compared with the empty-vector-transfected cells. Therefore, we hypothesized that the early spread of AITL tumor cells may be related to remodelling of the extracellular matrix. Accordingly, we observed a significant negative correlation between the relative area of collagen in histological sections from 18 primary AITL and the allele frequency of the RHOA-G17V mutation. In conclusion, our results suggest that the characteristic presentation of AITL with early, widespread dissemination of lymphoma cells is not the result of an enhanced migration capacity due to the RHOA-G17V mutation; instead, this feature may rather be related to extracellular matrix remodelling. MDPI 2023-06-17 /pmc/articles/PMC10296629/ /pubmed/37370838 http://dx.doi.org/10.3390/cancers15123226 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Merk-Ahmad, Katrin Bein, Julia Scharf, Sonja Schäfer, Hendrik Bexte, Tobias Ullrich, Evelyn Loth, Andreas G. Flinner, Nadine Senff, Tina Schneider, Olga Hansmann, Martin-Leo Piel, Matthieu Häupl, Björn Oellerich, Thomas Donnadieu, Emmanuel Hartmann, Sylvia The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title | The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title_full | The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title_fullStr | The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title_full_unstemmed | The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title_short | The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling |
title_sort | rhoa mutation g17v does not lead to increased migration of human malignant t cells but is associated with matrix remodelling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296629/ https://www.ncbi.nlm.nih.gov/pubmed/37370838 http://dx.doi.org/10.3390/cancers15123226 |
work_keys_str_mv | AT merkahmadkatrin therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT beinjulia therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT scharfsonja therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT schaferhendrik therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT bextetobias therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT ullrichevelyn therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT lothandreasg therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT flinnernadine therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT senfftina therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT schneiderolga therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hansmannmartinleo therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT pielmatthieu therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hauplbjorn therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT oellerichthomas therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT donnadieuemmanuel therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hartmannsylvia therhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT merkahmadkatrin rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT beinjulia rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT scharfsonja rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT schaferhendrik rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT bextetobias rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT ullrichevelyn rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT lothandreasg rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT flinnernadine rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT senfftina rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT schneiderolga rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hansmannmartinleo rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT pielmatthieu rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hauplbjorn rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT oellerichthomas rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT donnadieuemmanuel rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling AT hartmannsylvia rhoamutationg17vdoesnotleadtoincreasedmigrationofhumanmalignanttcellsbutisassociatedwithmatrixremodelling |